We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the H-coil Transcranial Magnetic Stimulation TMS Device - Safety and Feasibility Study for Acute and Maintenance Treatment in Major Depressive Episode

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00807105
First Posted: December 11, 2008
Last Update Posted: January 5, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Brainsway
Information provided by (Responsible Party):
Shalvata Mental Health Center
November 20, 2008
December 11, 2008
January 5, 2012
June 2008
May 2010   (Final data collection date for primary outcome measure)
response in HAMDS [ Time Frame: 1 YEAR ]
Same as current
Complete list of historical versions of study NCT00807105 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Evaluation of the H-coil Transcranial Magnetic Stimulation TMS Device - Safety and Feasibility Study for Acute and Maintenance Treatment in Major Depressive Episode
Not Provided
This is a prospective open label study of acute and maintenance treatment of MDD. The acute phase consists of daily treatments for 4 weeks. maintenance will be twice a week for eight weeks followed by 10 weeks of once a week treatments.
Not Provided
Interventional
Phase 2
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Major Depressive Disorder
Device: H-coil dTMS
treatment with deep TMS stimulation.
Experimental: depressive patients
patients suffering from deppresion
Intervention: Device: H-coil dTMS
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
29
May 2010
May 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • MDD patients

Exclusion Criteria:

  • risk factors for convulsions
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT00807105
0013-07 SHA
Yes
Not Provided
Not Provided
Shalvata Mental Health Center
Shalvata Mental Health Center
Brainsway
Not Provided
Shalvata Mental Health Center
January 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP